Sage Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Short Maturity Bond ETF
NEAR
|
+$3.74M |
| 2 |
Molson Coors Class B
TAP
|
+$3.48M |
| 3 |
WRK
WestRock Company
WRK
|
+$3.25M |
| 4 |
State Street
STT
|
+$1.86M |
| 5 |
Cardinal Health
CAH
|
+$1.63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$2.6M |
| 2 |
Biogen
BIIB
|
+$1.58M |
| 3 |
Apple
AAPL
|
+$1.24M |
| 4 |
Global X Alternative Income ETF
ALTY
|
+$814K |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$481K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.25% |
| 2 | Financials | 15.16% |
| 3 | Industrials | 12.31% |
| 4 | Healthcare | 12.26% |
| 5 | Communication Services | 7.03% |
Similar funds
Sage Capital Advisors's Q4 2019 Portfolio in Review
As of Q4 2019, Sage Capital Advisors held 107 positions worth $158M, up 19% from $133M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Sage Capital Advisors deployed $11.2M of net new capital in Q4 2019, opening 10 new positions and adding to 72 existing holdings. Its largest new stake was iShares Short Maturity Bond ETF: 74,404 shares worth $3.74M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Kellanova, an estimated $2.6M trimmed.
- Sage Capital Advisors's largest Q4 2019 buy was iShares Short Maturity Bond ETF: 74,404 shares worth $3.74M.
- Sage Capital Advisors added most to Cardinal Health in Q4 2019, an estimated $1.63M increase.
- Sage Capital Advisors's biggest Q4 2019 reduction was Kellanova, cutting an estimated $2.6M.
- Sage Capital Advisors fully exited Biogen in Q4 2019, selling an estimated $1.58M.
- Sage Capital Advisors's ten largest holdings make up 38% of its $158M portfolio in Q4 2019.
- Sage Capital Advisors opened 10 new positions and closed 5 in Q4 2019.
- Sage Capital Advisors's portfolio value rose 19% quarter-over-quarter to $158M.
Based on Sage Capital Advisors's 13F filing for Q4 2019, filed 16 Jan 2020.